The intelligent use of systemic glucocorticoids in rheumatoid arthritis

Cecilia Mercieca, John R Kirwan

Research output: Contribution to journalArticle (Academic Journal)peer-review

2 Citations (Scopus)

Abstract

Glucocorticoids (GC) have potent anti-inflammatory and immunomodulatory effects and are widely used in the management of rheumatoid arthritis in combination with other disease-modifying anti-rheumatoid drugs. Concern about the risk of adverse effects may be to some extent misplaced as low to moderate doses of GC have different mechanisms of action and risk profiles compared with high doses. This review discusses the current understanding about the different modes of action of GC, their strong disease-modifying properties and the efforts at improving the therapeutic ratio of GC through the development of new drugs which promise greater safety such as selective GC receptor agonists, liposomal GC and modified-release (MR) prednisone.
Original languageEnglish
JournalExpert Review of Clinical Immunology
DOIs
Publication statusPublished - 2 Dec 2013

Fingerprint Dive into the research topics of 'The intelligent use of systemic glucocorticoids in rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this